Franz B. Humer - Dec 5, 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
Earl Douglas, Attorney-in-fact
Stock symbol
ALLO
Transactions as of
Dec 5, 2024
Transactions value $
-$19,917
Form type
4
Date filed
12/9/2024, 04:05 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale -$19.9K -9.22K -2.91% $2.16 308K Dec 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.145 to $2.185, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Remarks:

Exhibits: Power or Attorney